1. Home
  2. SHMD vs GBIO Comparison

SHMD vs GBIO Comparison

Compare SHMD & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHMD
  • GBIO
  • Stock Information
  • Founded
  • SHMD 1864
  • GBIO 2016
  • Country
  • SHMD Germany
  • GBIO United States
  • Employees
  • SHMD N/A
  • GBIO N/A
  • Industry
  • SHMD
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • SHMD
  • GBIO Health Care
  • Exchange
  • SHMD Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • SHMD 171.9M
  • GBIO 145.5M
  • IPO Year
  • SHMD N/A
  • GBIO 2020
  • Fundamental
  • Price
  • SHMD $3.72
  • GBIO $2.50
  • Analyst Decision
  • SHMD
  • GBIO Buy
  • Analyst Count
  • SHMD 0
  • GBIO 4
  • Target Price
  • SHMD N/A
  • GBIO $7.50
  • AVG Volume (30 Days)
  • SHMD 25.7K
  • GBIO 64.5K
  • Earning Date
  • SHMD 09-24-2024
  • GBIO 08-07-2024
  • Dividend Yield
  • SHMD N/A
  • GBIO N/A
  • EPS Growth
  • SHMD N/A
  • GBIO N/A
  • EPS
  • SHMD N/A
  • GBIO N/A
  • Revenue
  • SHMD N/A
  • GBIO $13,174,000.00
  • Revenue This Year
  • SHMD N/A
  • GBIO $99.36
  • Revenue Next Year
  • SHMD N/A
  • GBIO N/A
  • P/E Ratio
  • SHMD N/A
  • GBIO N/A
  • Revenue Growth
  • SHMD 79.48
  • GBIO 1397.05
  • 52 Week Low
  • SHMD $2.69
  • GBIO $0.86
  • 52 Week High
  • SHMD $6.13
  • GBIO $4.65
  • Technical
  • Relative Strength Index (RSI)
  • SHMD N/A
  • GBIO 49.32
  • Support Level
  • SHMD N/A
  • GBIO $2.13
  • Resistance Level
  • SHMD N/A
  • GBIO $2.49
  • Average True Range (ATR)
  • SHMD 0.00
  • GBIO 0.21
  • MACD
  • SHMD 0.00
  • GBIO 0.01
  • Stochastic Oscillator
  • SHMD 0.00
  • GBIO 46.91

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: